Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-31,031
Closed -$76K 1837
2023
Q3
$76K Buy
+31,031
New +$148K 0.01% 868
2022
Q3
Sell
-6,151
Closed -$27K 2018
2022
Q2
$27K Buy
6,151
+677
+12% +$4.66K ﹤0.01% 1271
2022
Q1
$46K Sell
5,474
-16,866
-75% -$143K ﹤0.01% 1158
2021
Q4
$214K Buy
+22,340
New +$260K 0.02% 806
2021
Q3
Sell
-8,661
Closed -$130K 1779
2021
Q2
$130K Buy
8,661
+2,389
+38% +$37.5K 0.01% 1132
2021
Q1
$104K Sell
6,272
-10,828
-63% -$205K 0.01% 1310
2020
Q4
$290K Buy
+17,100
New +$421K 0.03% 655
2018
Q2
Sell
-13,607
Closed -$157K 2297
2018
Q1
$157K Buy
+13,607
New +$163K 0.01% 1447

Other funds holding MESO

Virtu Financial's MESO Position: Q4 2023 in Review

Virtu Financial sold out of Mesoblast (MESO) in Q4 2023, closing a stake of 31,031 shares — an estimated $76K sold.

Virtu Financial first reported a position in MESO in Q1 2018 and held it in 8 quarters. The position peaked at $290K in Q4 2020. 31 funds tracked by Wall St. Rank hold MESO as of Q4 2023.

  • Virtu Financial reported no remaining Mesoblast position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 31,031 Mesoblast shares in Q4 2023, an estimated $76K.
  • Virtu Financial first reported a position in Mesoblast in Q1 2018 and held it in 8 quarters.
  • Virtu Financial's Mesoblast position peaked at $290K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Mesoblast as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.